The predictive value for prostate cancer of lesions that raise suspicion of concomitant carcinoma: An evaluation from a randomized, population-based study of screening for prostate cancer

Cancer

Volumn 92, Issue 3, 2001, Pages 524-534

  Vis, André N ^a,b   Hoedemaeker, Robert F ^a   Roobol, Monique ^b   Schröder, Fritz H ^b   van der Kwast, Theo H ^a  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Atypia; Biopsy; Prostatic adenocarcinoma; Prostatic intraepithelial neoplasia; Screening; Suspicious lesions

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY;

AGED; BIOPSY; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS;

EID: 0035424570     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010801)92:3<524::AID-CNCR1351>3.0.CO;2-A     Document Type: Article

References (43)

1. The focus of "atypical glands, suspicious for malignancy" in prostatic needle biopsy specimens
2. Diagnosis of "suspicious for malignancy" in prostate biopsies: Predictive value for cancer
3. Evaluation of prostatic needle biopsies in a population-based screening study: The impact of borderline lesions
4. High grade prostatic intraepithelial neoplasia. The most likely precursor of prostate cancer
5. The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies
6. Androgen deprivation as a strategy for prostate cancer chemoprevention
7. Reversibility of prostatic intraepithelial neoplasia: Implications for chemo-prevention
8. Repeat screening for prostate cancer after 1-year follow-up in 984 biopsied men: Clinical and pathological features of detected cancer
9. Changing role of three screening modalities in the European Randomized Study of Screening for Prostate Cancer (Rotterdam)
10. Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region)
11. Evaluation of digital rectal examination as a screening test for prostate cancer
12. Histologic grading of prostate cancer: A perspective
13. Histologic grading study of prostatic adenocarcinoma: The development of a new system and comparison with other methods - A preliminary study
14. Architectural patterns of high-grade prostatic intra-epithelial neoplasia
15. Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations
16. Morphometric and clinical studies on 68 consecutive radical prostatectomies
17. The Biomed II MPC Study group, Processing radical prostatectomy specimens
18. Comparison of pathological characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer
19. Pathological and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer
20. The pathological features and prognosis of prostate cancer detectable with current diagnostic tests
21. Defining a window of opportunity in screening for prostate cancer: Validation of a predictive tumor classification model
22. Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia
23. Morphometric analysis and clinical follow-up of isolated prostatic intraepithelial neoplasia in needle biopsy of the prostate
24. Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia
25. Strategy for repeated biopsy in patients with high grade prostatic intraepithelial neoplasia
26. Analysis of 3300 consecutive prostate biopsies: A 4 year institutional experience with the frequency of carcinoma, isolated high-grade intraepithelial neoplasia, and "atypical"
27. Diagnoses rendered on prostate needle biopsy in community hospitals
28. Incidence of high-grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens
29. Analysis of repeated biopsy results within 1 year after a noncancer diagnosis
30. Significance of prostatic intra-epithelial neoplasia on prostatic needle biopsy
31. Significance of high-grade prostatic intra-epithelial neoplasia on needle biopsy
32. Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: Predictive accuracy in needle biopsies
33. Repeat prostate biopsy: Who needs it?
34. Strategy for repeat biopsy of patients with prostatic intraepithelial neoplasia detected by prostate needle biopsy
35. Repeat biopsy in men with isolated prostatic intraepithelial neoplasia on prostate needle biopsy
36. Prostatic intraepithelial neoplasia: Influence of clinical and pathological data on the detection of prostate cancer
37. Extensive repeat transrectal ultrasound-guided prostate biopsy in patients with previous benign sextant biopsies
38. Predictors of first repeated biopsy cancer detection with suspected local stage prostate cancer
39. The presence of atypical small acinar proliferations in prostate needle biopsy is predictive of carcinoma on subsequent biopsy
40. Follow-up of atypical prostate needle biopsies suspicious for cancer
41. Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: Clinical significance in 33 cases
42. The diagnosis of "suspicious" for adenocarcinoma in prostate biopsies: Evaluation of follow-up biopsies
43. Repeat biopsy strategies for men with atypical diagnoses on initial prostate needle biopsy